Cyclobenzaprine Hydrochloride

Product NDC
53002-3080
11-digit product format
530023080
Labeler code
53002
Product ID
53002-3080_c8f550ff-b040-40d3-ad88-c88a1cb67b04
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Cyclobenzaprine
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
RPK Pharmaceuticals, Inc.
Application
ANDA090478
Marketing category
ANDA
Marketing start
2016-07-22
Marketing end
0000-00-00
Substance
CYCLOBENZAPRINE HYDROCHLORIDE
Active strength
10 mg/1
Pharmacologic classes
Centrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC]
NDC exclude flag
No
Listing certified through
2021-12-31
Current FDA listing
Historical FDA.report record

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
51048710-225c-aa41-d0e7-eed095d02838Product name420250331
c2c26dc9-7e16-fc02-7eba-6b46ed3515eeProduct name120140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
53002-3080-12025-01-30C16284748780-19d75b9d0-6ee0-f424-e053-dadaa90a57ceCYCLOBENZAPRINE HCl TABLETS USP
53002-3080-22025-01-30C16284748780-19d75b9d0-6ee0-f424-e053-dadaa90a57ceCYCLOBENZAPRINE HCl TABLETS USP
53002-3080-32025-01-30C16284748780-19d75b9d0-6ee0-f424-e053-dadaa90a57ceCYCLOBENZAPRINE HCl TABLETS USP
53002-3080-42025-01-30C16284748780-19d75b9d0-6ee0-f424-e053-dadaa90a57ceCYCLOBENZAPRINE HCl TABLETS USP
53002-3080-52025-01-30C16284748780-19d75b9d0-6ee0-f424-e053-dadaa90a57ceCYCLOBENZAPRINE HCl TABLETS USP
53002-3080-12023-06-07C16284748780-19d75b9d0-6ee0-f424-e053-dadaa90a57ceCYCLOBENZAPRINE HCl TABLETS USP
53002-3080-22023-06-07C16284748780-19d75b9d0-6ee0-f424-e053-dadaa90a57ceCYCLOBENZAPRINE HCl TABLETS USP
53002-3080-32023-06-07C16284748780-19d75b9d0-6ee0-f424-e053-dadaa90a57ceCYCLOBENZAPRINE HCl TABLETS USP
53002-3080-42023-06-07C16284748780-19d75b9d0-6ee0-f424-e053-dadaa90a57ceCYCLOBENZAPRINE HCl TABLETS USP
53002-3080-52023-06-07C16284748780-19d75b9d0-6ee0-f424-e053-dadaa90a57ceCYCLOBENZAPRINE HCl TABLETS USP
53002-3080-12023-01-30C16284748780-19d75b9d0-6ee0-f424-e053-dadaa90a57ceCYCLOBENZAPRINE HCl TABLETS USP
53002-3080-22023-01-30C16284748780-19d75b9d0-6ee0-f424-e053-dadaa90a57ceCYCLOBENZAPRINE HCl TABLETS USP
53002-3080-32023-01-30C16284748780-19d75b9d0-6ee0-f424-e053-dadaa90a57ceCYCLOBENZAPRINE HCl TABLETS USP
53002-3080-42023-01-30C16284748780-19d75b9d0-6ee0-f424-e053-dadaa90a57ceCYCLOBENZAPRINE HCl TABLETS USP
53002-3080-52023-01-30C16284748780-19d75b9d0-6ee0-f424-e053-dadaa90a57ceCYCLOBENZAPRINE HCl TABLETS USP
53002-3080-12020-12-15C16284748780-19d75b9d0-6ee0-f424-e053-dadaa90a57ceCYCLOBENZAPRINE HCl TABLETS USP
53002-3080-22020-12-15C16284748780-19d75b9d0-6ee0-f424-e053-dadaa90a57ceCYCLOBENZAPRINE HCl TABLETS USP
53002-3080-32020-12-15C16284748780-19d75b9d0-6ee0-f424-e053-dadaa90a57ceCYCLOBENZAPRINE HCl TABLETS USP
53002-3080-42020-12-15C16284748780-19d75b9d0-6ee0-f424-e053-dadaa90a57ceCYCLOBENZAPRINE HCl TABLETS USP
53002-3080-52020-12-15C16284748780-19d75b9d0-6ee0-f424-e053-dadaa90a57ceCYCLOBENZAPRINE HCl TABLETS USP
53002-3080-12020-01-31C16284748780-19d75b9d0-6ee0-f424-e053-dadaa90a57ceCYCLOBENZAPRINE HCl TABLETS USP
53002-3080-22020-01-31C16284748780-19d75b9d0-6ee0-f424-e053-dadaa90a57ceCYCLOBENZAPRINE HCl TABLETS USP
53002-3080-32020-01-31C16284748780-19d75b9d0-6ee0-f424-e053-dadaa90a57ceCYCLOBENZAPRINE HCl TABLETS USP
53002-3080-42020-01-31C16284748780-19d75b9d0-6ee0-f424-e053-dadaa90a57ceCYCLOBENZAPRINE HCl TABLETS USP
53002-3080-52020-01-31C16284748780-19d75b9d0-6ee0-f424-e053-dadaa90a57ceCYCLOBENZAPRINE HCl TABLETS USP

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
53002-3080-1Cyclobenzaprine Hydrochloride5 in 1 BOTTLETABLET, FILM COATED55
53002-3080-2Cyclobenzaprine Hydrochloride10 in 1 BOTTLETABLET, FILM COATED105
53002-3080-3Cyclobenzaprine Hydrochloride15 in 1 BOTTLETABLET, FILM COATED155
53002-3080-4Cyclobenzaprine Hydrochloride21 in 1 BOTTLETABLET, FILM COATED215
53002-3080-5Cyclobenzaprine Hydrochloride30 in 1 BOTTLETABLET, FILM COATED305

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
53002-3080CYCLOBENZAPRINE HYDROCHLORIDE (CYCLOBENZAPRINE) TABLET, FILM COATED [RPK PHARMACEUTICALS, INC.]5Legacy NDC, 5 package rows20230609_2ff7cb40-9b43-47fb-a7b4-f9e6e9d65e5b.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
828348cyclobenzaprine HCl 10 MG Oral TabletPSN2ff7cb40-9b43-47fb-a7b4-f9e6e9d65e5b5
828348cyclobenzaprine hydrochloride 10 MG Oral TabletSCD2ff7cb40-9b43-47fb-a7b4-f9e6e9d65e5b5

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
53002-3080-1530023080015 TABLET, FILM COATED in 1 BOTTLE (53002-3080-1) 2017-10-010000-00-00NoNoCurrent
53002-3080-25300230800210 TABLET, FILM COATED in 1 BOTTLE (53002-3080-2) 2017-10-010000-00-00NoNoCurrent
53002-3080-35300230800315 TABLET, FILM COATED in 1 BOTTLE (53002-3080-3) 2017-10-010000-00-00NoNoCurrent
53002-3080-45300230800421 TABLET, FILM COATED in 1 BOTTLE (53002-3080-4) 2017-10-010000-00-00NoNoCurrent
53002-3080-55300230800530 TABLET, FILM COATED in 1 BOTTLE (53002-3080-5) 2017-10-010000-00-00NoNoCurrent